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Association of time on outcome after
intravenous thrombolysis in the elderly in a
telestroke network
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Jessica Kepplinger MD, Lars-Peder Pallesen MD, Volker Puetz MD
and Ulf Bodechtel MD
Abstract
Background: Recent studies showed that the safety and benefit of early intravenous (IV) thrombolysis on favourable outcomes
in acute ischemic stroke are also seen in the elderly. Furthermore, it has shown that age increases times for pre- and in-hospital
procedures. We aimed to assess the applicability of these findings to telestroke.
Methods: We retrospectively analysed 542 of 1659 screened consecutive stroke patients treated with IV thrombolysis in our
telestroke network in East-Saxony, Germany from 2007 to 2012. Outcome data were symptomatic intracranial hemorrhage
(sICH) by ECASS-2-criteria, survival at discharge and favourable outcome, defined as a modified Rankin scale (mRS) of 0–2 at
discharge.
Results: Thirty-three percent of patients were older than 80 years (elderly). Being elderly was associated with higher risk of sICH
(p¼ 0.003), less favourable outcomes (p¼ 0.02) and higher mortality (p¼ 0.01). Using logistic regression analysis, earlier onset-
to-treatment time was associated with favourable outcomes in not elderly patients (adjusted odds ratio (OR) 1.18; 95% CI 1.03–
1.34; p¼ 0.01), and tended to be associated with favourable outcomes (adjusted OR 1.13; 95% CI 0.92–1.38; p¼ 0.25) and less
sICH (adjusted OR 0.88; 95% CI 0.76–1.03; p¼ 0.11) in elderly patients. Age caused no significant differences in onset-to-door-
time (p¼ 0.25), door-to-treatment-time (p¼ 0.06) or onset-to-treatment-time (p¼ 0.29).
Conclusion: Treatment time seems to be critical for favourable outcome after acute ischemic stroke in the elderly. Age is not
associated with longer delivery times for thrombolysis in telestroke.
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Introduction
Although stroke is more common in old age, elderly
patients were excluded or underrepresented in the major-
ity of acute revascularization studies. Therefore, in the
European Union and several other countries intravenous
(IV) thrombolysis is restricted to patients <80 years.
Despite patients >80 years of age having a lower prob-
ability of gaining functional outcome and a higher mor-
tality rate due to higher stroke severity, concurrent
medical problems, prestroke disability, and less-aggressive
management there is still a benefit for those patients to be
treated within 3.5 hours and even within 4.5 hours of
stroke onset.1–3
The quality of treatment, complication rates, and short
and long term outcomes are similar for acute stroke
patients treated with IV tissue plasminogen activator
(tPA) via a telemedicine consultation at local hospitals
and those treated in specialized stroke centres.4–13
We sought to assess the safety and benefits of early
thrombolysis in the elderly (>80) within a telestroke net-
work. Moreover, we wanted to evaluate whether age is
associated with longer delivery and treatment times in a
telestroke network compared to younger patients (<80
years) since IV thrombolysis is not administered routinely
to elderly patients with acute ischemic stroke in rural set-
tings. An observational study found that age affected
increasing times for pre- and in-hospital procedures.14
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Methods
Stroke Eastern Saxony Network
The Stroke Eastern Saxony Network (SOS-NET) was
established as a telemedical stroke network by the
Dresden University Stroke Center (DUSC) in 2007 and
provides stroke care for 14 smaller community hospitals.
Stroke neurologists from the DUSC are available 24/7.
Teleconsultations consisted of the patient history, a
structured clinical assessment using the National
Institutes of Health Stroke Scale (NIHSS) score and a
standardized evaluation of the transferred CT scans
using the Alberta Stroke Program Early CT Score
(ASPECTS).6,7
Patients
We performed a retrospective cohort study. We included
all consecutive SOS-NET patients who had clinically
suspected acute ischemic stroke and received IV thromb-
olysis after telemedical consultation during a five year
period (07/2007 to 07/2012). Patients with primary diag-
noses other than clinical suspected acute ischemic stroke
(e.g. primary intracerebral hemorrhage (ICH), intracra-
nial tumour, epileptic seizure, transient ischemic attack,
and psychological disorders) were excluded from the
study. We also excluded patients who did not receive
IV thrombolysis after initial recommendation by the
stroke neurologist and patients with missing documen-
tation of the outcome measures.
Clinical data were prospectively collected with SOS-
NET quality assurance forms, which were completed by
the affiliated hospitals according to the German Stroke
Registries Study Group guidelines including occurrence
of symptomatic intracerebral hemorrhage (sICH) and
modified Rankin scale (mRS) score at discharge.15
Missing data and additional data with clinical relevance
(blood pressure before IV thrombolysis, baseline glucose
levels, time of symptom onset and time of IV thromboly-
sis) were retrospectively derived from in-patient records or
were imputed using available data.
This study was approved by the Dresden University of
Technology ethics committee (EK293082011).
Outcome measures
The clinical outcome measure was sICH on follow-up
images defined by the European cooperative acute
stroke study II (ECASS-II) criteria (hemorrhagic trans-
formation of infarction causing a neurological deterior-
ation with an increase of NIHSS score by more than
three points) as documented in quality assurance
forms.16 Follow-up images were performed within 48
hours of thrombolysis. Fatal sICH were defined as sICH
resulting in mRS score of 6 at discharge. An additional
outcome measure was favourable functional outcome at
discharge defined as modified mRS scores of 0–2 as well as
survival at discharge.
Statistical analysis
Measures of central tendency and measures of variability
were used according to standard descriptive statistics.
We imputed 38 missing values for onset-to-needle-time
and 44 missing values for systolic blood pressure with
the median values of the available data. Fifty-six missing
values for baseline glucose levels were imputed with the
mean value of the available data.
We used a chi-squared test to demonstrate the associ-
ation between the dichotomized age and the outcome
measures. We finally developed multivariable regression
models to test whether there are clinical predictors for
the association between dichotomized age and the out-
come measures. The model development was based upon
the step-wise manual elimination of variables using bivari-
ate analysis. For the final parsimonious model, we
included only variables that were relevant a priori (base-
line systolic blood pressure and glucose levels, baseline
NIHSS score and categorical (30 minute periods) onset-
to-treatment time) and were predictive of the outcome in
bivariate analysis (p< 0.2).
The scatter plot of the frequency of favourable out-
come and onset-to-treatment time (categorical, 30 minutes
periods) was completed with a logarithmic trend line
because the rate of change in frequencies of favourable
functional outcome decreased quickly and then levelled
out. We calculated R-squared value (coefficient of deter-
mination). For the benefit of early thrombolysis we per-
formed a meta-analysis with the results from logistic
regression analysis stratified by age and created a forest
plot using the step-by-step guide developed by Neyeloff
et al.17
Statistical analysis was performed using Microsoft
Excel.
Results
Patient population
Among 3172 teleconsultations which were performed
from 07/2007 to 07/2012, 1513 patients had non-ischemic
diagnoses. Among 1659 patients with clinically suspected
ischemic stroke, stroke neurologists recommended IV
thrombolysis in 688 patients (41.5%) and 657 patients
(39.6%) finally received IV thrombolysis.
Of the 657 patients who received IV thrombolytics, we
excluded 115 patients as the outcome measures (sICH,
mRS) were not documented in the quality assurance
forms or the in-patients records. We therefore included
542 patients with complete clinical data into the analysis
(Figure 1). The clinical baseline characteristics are sum-
marized in Table 1.
The thrombolysis rate of the elderly patients was higher
than those of the younger patients (180/454 patients
(39.6%) vs. 362/1205 patients (30%); p-value <0.01).
Thirty-three of 542 patients (6.1%) suffered sICH.
Overall, at discharge, 179 patients (33%) had a favourable
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Figure 1. Flowchart of study population.
IV: intravenous; ICB: Intracranial Bleed; TIA: Transitoric Ischemic Attack.
Table 1. Clinical baseline characteristics.
Not elderly (480 years) Elderly (>80 years) P-value
Total, n 362 180
Female, n (%) 165 (45.6) 126 (70.0)
Age, years, median (IQR) [mean; SD] 72 (5) [69,2; 9,9] 84 (5) [84,6; 3,3]
NIHSS score, median (IQR) 11 (11) 14 (10) <0.01
Systolic blood pressure, mmHg, median (IQR) 155 (5) 155 (14) 0.16
Glucose level, mmol/l, mean (SD) 7.57 (2.32) 7.52 (2.43) 0.84*
Onset-to-door-time, minutes, median (IQR) 65 (65) 73 (37.75) 0.02*
Door-to-needle-time, minutes, median (IQR) 70 (38.5) 73 (37.75) 0.47*
Onset-to-needle-time, minutes, median (IQR) 145 (41.25) 145 (47) 0.34*
Cardiovascular risk factors
Hypertension, n (%) 312 (86.2) 163 (90.6) 0.15
Hyperlipidaemia, n (%) 205 (56.6) 75 (41.7) <0.01
Diabetes, n (%) 172 (47.5) 77 (42.8) 0.30
Atrial fibrillation, n (%) 144 (39.8) 110 (61.1) <0.01
Carotid stenosis, n (%) 63 (17.4) 25 (13.9) 0.30
Previous stroke, n (%) 68 (18.8) 41 (22.8) 0.27
P values are Mann–Whitney U test, student’s t-test* (2-tailed) or chi-squared test.
NIHSS: National Institute of Health Stroke Scale; IQR: interquartile range; mmHg: millimeters of mercury; mmol/l: millimoles per liter.
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functional outcome (mRS scores 0–2), 262 patients
(48.3%) had an unfavourable functional outcome (mRS
scores 3–5) and 101 (18.6%) patients had died.
The final clinical diagnoses were cerebral ischemic
events in 539 patients (99.4%) and stroke mimics in
three patients (0.6%). None of the patients with stroke
mimics had sICH.
Elderly and non-elderly patient had significantly different
stroke baseline severity (median 14 interquartile range (IQR)
10) vs. median 11 (IQR 11); p-value <0.01), rate of hyper-
lipidemia (75/180 patients (41.7%) vs. 205/362 patients
(56.6%); p-value <0.01) and atrial fibrillation (110/180
patients (61.1%) vs. 144/362 (39.8%); p-value <0.01).
Association of age and outcome measures
The sICH rate was higher in the elderly (19/180 patients
(10.6%) vs. 14/362 patients (3.9%), respectively;
p-value¼ 0.003). Being elderly was also associated with
lower frequency of favourable functional outcome (47/180
patients (26.1%) vs. 132/362 patients (36.5%);
p-value¼ 0.02) and lower survival rate at discharge (136/
180 patients (75.6%) vs. 305/362 patients (84.3%);
p-value¼ 0.01) compared to their younger counterparts.
In logistic regression analysis adjusted for NIHSS and
baseline blood pressure, elderly patients were 2.6 times
more likely to suffer sICH (adjusted OR 2.58; 95% confi-
dence interval (CI) 1.25–5.33; p-value¼ 0.01). The fre-
quency of fatal sICH was similar in both the elderly and
not elderly relative to the sICH occurrences in each group
(12/19 patients (63.2%) vs. 9/14 patients (64.3%);
p-value¼ 0.95).
Effect of treatment delay
The majority of elderly and non-elderly patients were trea-
ted within 180 minutes (142/180 patients (78.9%) vs. 292/
362 patients (80.7%); p-value¼ 0.63).
Using logistic regression analysis, earlier onset-to-
treatment (per 30 minute increase) tended to be associated
with favourable outcome (adjusted OR 1.13; 95% CI
0.92–1.38; p¼ 0.25) in elderly patients. Detailed results
and the forest plot are displayed in Figure 2.
The logarithmic trend lines (Figure 3) fitted for the
plotted frequency of favourable outcome and onset-to-
treatment time were similar but showed a stronger
decrease for elderly patients (y¼ –0.106 ln(x)þ 0.7436;
R-squared value¼ 0.24) compared to not elderly patients
(y¼ –0.083 ln(x)þ 0.8145; R-squared value¼ 0.23).
Additionally, elderly patients tended to have fewer
sICH when treated earlier (adjusted OR 0.88; 95% CI
0.76–1.03; p¼ 0.11).
Figure 2. Forest plot of odds ratio for functional outcome depending on onset-to-treatment time, by age.
Derived from a logistic regression analysis stratified by age, which enabled separate estimation of odds ratio after adjustment for two other
baseline characteristics (NIHSS, baseline blood pressure).
NIHSS: National Institute of Health Stroke Scale; OTT: Onset-to-Treatment Time; RR: Riva-Rocci; mmHg: millimeter of mercury.
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There was no significant difference in either onset-
to-door-time (p-value¼ 0.25), door-to-treatment-time
(p-value¼ 0.06) or onset-to-treatment-time (p-value¼
0.29) between elderly and not elderly patients.
Discussion
Telemedical thrombolysis itself seems to be safe, with an
overall sICH rate in our study (6.1%) which was similar to
other stroke thrombolysis trials.18 In our study 10.6% of
elderly patients suffered sICH, whereas other studies
reported sICH rates ranging from 2.4% to 13%, compar-
able or higher than their younger counterparts.19,20 With
every 30 minutes saved in onset-to-treatment time, elderly
people are 0.88 times less likely to suffer sICH.
However, the higher bleeding rate may not be respon-
sible for the higher mortality rate in elderly patients since
the frequency of fatal sICH was similar in both groups.
Death in acute stroke patients is mostly caused by pneu-
monia and other complications of stroke. Greater stroke
severity, increased prestroke dependency, and frequency
of atrial fibrillation and heart failure are factors that
contribute to the increased mortality in those older than
80 years.21
Our data indicate that the benefit of early thrombolysis
in elderly patients on functional outcome also applies to
telestroke networks. Although the association between
onset-to-treatment time and favourable outcome was not
significant, the odds ratio was similar to the one calculated
for not elderly patients. The findings might be relevant to
facilitate thrombolysis rates in neurologically underserved
areas, especially since the predicted ageing of our population
will lead to roughly 400 million persons worldwide aged
80 years or over in the year 2050.22 Regional stroke care
systems should accelerate treatment as much as possible.
A previous observational study reported delayed treat-
ment times for patients aged 80 years and over.14 In our
study, however, the majority of patients, both elderly and
not elderly, were treated within less than 180 minutes from
stroke onset. There was no significant difference in treat-
ment times for pre- and in-hospital procedures for elderly
and not elderly patients. This finding might be a result of
the continuous cooperation between hospitals within a
telestroke network and could be also relevant for the
Figure 3. Effect of treatment delay.
Scatter plot of frequency of favourable outcome per categorical onset-to-treatment time (30 minute periods). Blue dots are for not elderly
patients, red dots are for elderly patients. Logarithmic trend lines indicate lines of best fit.
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organization of regional stroke care in neurologically
underserved areas.
The thrombolysis rate was even higher for elderly patients
compared to their younger counterparts. This might due to a
selection bias in the community hospitals. Physicians tended
to present younger patients despite a time window >4.5
hours and with minimal stroke severity whereas elderly
patients were more often presented when thrombolysis
seemed likely, thus leading to more frequent recommenda-
tion of thrombolysis in the elderly. The increased stroke
severity in the elderly could be a result of the high rate of
atrial fibrillation causing proximal stenosis of the cerebral
arteries with greater infarct volume in the elderly. We have
no data about whether atrial fibrillation was known before
hospitalization and patients were insufficiently anticoagu-
lated or if the diagnosis was newly made.
The number of stroke mimics in our population was
smaller than in other stroke thrombolysis studies; none
of the three patients with stroke mimics suffered
sICH.23,24 Although the number was very small, thromb-
olysis in stroke mimics seems also to be safe in telestroke
care. The affiliated hospitals do not have neurology ser-
vice coverage and their experience and expertise with
neurological disorders is limited. We therefore suspect
that the low number of stroke mimics stems from an
inability of extensive neurological workup (electromyo-
gram, electroencephalogram, MRI, spinal tap, etc.) and
a tendency to stay with the initial diagnosis given by the
teleconsultant.
Our study is limited by its retrospective design and the
data imputation. We had to exclude 17.5% of the throm-
bolysed patients from our analysis due to missing outcome
data. This could have introduced a selection bias into
our analysis by either excluding many favourable or
unfavourable outcomes that remained unknown to us.
Furthermore, we only had documented mRS scores at
discharge, but it has been shown that these have a high
predictive value for functional outcome at three months
poststroke.25 Although prestroke disability and concur-
rent medical problems influence the functional outcome
in elderly patients as well, we could not account for
those factors in our statistical analysis since no according
data were available. We had a low coefficient of determin-
ation (R-squared value 0.23 and 0.24, respectively) when
using a logarithmic trend line to show the benefit of earlier
thrombolysis in our scatter plot. Our sample size was
smaller compared to previous studies, which caused
highly variable frequencies of favourable outcome for
the categorical onset-to-treatment time, thus resulting in
a low representativeness of the trend line.3
Conclusion
Shorter time and younger age is associated with favour-
able outcome after telestroke mediated thrombolysis.
However, even in the elderly, time seems to be critical
for favourable outcome. Age is not associated with
longer delivery times for thrombolysis in a telestroke net-
work in rural areas.
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